Healthcare workers, academic and medical researchers, colleagues, community and other New York heroes — here are their stories and latest news.
Dr. Philip O. Ozuah, President and CEO, Montefiore Medicine, on ESPN. As Michael Kay announced on his Podcast yesterday: “I have never on social media seen total unanimity that I’m glad you guys had him on because he really helped educate us.”
Montefiore received one of the nation's highest honors for treating behavioral needs in primary care settings from the National Committee for Quality Assurance (NCQA). Our primary care providers are addressing behavioral health, including COVID-19-related depression and anxiety, and improving care access, experience and patient outcomes.
Montefiore-Einstein’s live-stream COVID-19 Remembrance Ceremony 2021: In honor of those lost and those who come together, every day, to heal New York. The ceremony is hosted by Dr. Philip O. Ozuah, President and CEO of Montefiore Medicine, and features performances by Jon Batiste, Orchestra of the Bronx, Every Voice Choirs and Sing Harlem from Mama Foundation for the Arts, with special guests, Montefiore-Einstein’s healthcare heroes.
The findings, published online in Nature Cancer, may lead to better care for cancer patients, who face a heightened risk of dying from COVID-19, and suggests that cancer patients should respond well to COVID-19 vaccines.
Montefiore-Einstein’s Dr. Anne Felicia Ambrose, MS, Director of Research and Associate Professor of Rehabilitation Medicine, speaks to Healio about preliminary research findings that demonstrate the benefits of physical therapy for patients with COVID-19.
A study led by Montefiore-Einstein’s Dr. Emad Nader Eskandar shows there’s a higher risk for in-hospital mortality independent of COVID-19 disease severity for hospitalized COVID-19 patients with altered mental status or stroke upon admission.
Dr. Zingman, Clinical Director, Infectious Diseases and Professor of Medicine, Montefiore-Einstein discusses the health system's efforts to ensure communities hit hardest by COVID-19 - people of color, health care workers, and people over 65 - are included in the AstraZeneca vaccine trial. Watch the full segment here.
Montefiore-Einstein’s Ulrich P. Jorde, MD, Vice Chief, Division of Cardiology, senior author of the study shares principal finding that statin use was associated with a dramatically reduced risk of death from COVID‑19 in hospitalized patients with diabetes.
Dr. Aluko Hope, Co-director, COVID-19 Recovery (CORE) Clinic and Associate Professor, Montefiore-Einstein speaks to NPR about coronavirus "long-haulers," and the prolonged or new symptoms that may occur months after getting COVID‑19.
The FDA has approved the antiviral drug remdesivir (brand name: Veklury), for the treatment of hospitalized #COVID19 patients. “The approval of Veklury marks an important milestone in efforts to help address the pandemic by offering an effective treatment that helps patients recover faster,” said Montefiore-Einstein's Barry Zingman, MD, Director, Infectious Diseases, Moses Division, Montefiore Health System about the new approval.
Dr. Philip Ozuah shares his hope that during this moment, people will fight to eradicate racism while also working to end the coronavirus pandemic.
We are open for elective surgeries and procedures. For everyone’s safety, we have designated treatment areas for non-COVID-19 patients, and we have gone beyond industry standards to implement the most rigorous COVID-SAFE Care protocols currently available. Now more than ever, it’s important to not put your healthcare needs on hold.
Out-of-hospital heart attacks in NYC nearly tripled during the height of the COVID-19 pandemic—peaking on April 6, 2020 with 305 cases, an almost 10x increase from the same day in 2019—according to a study published in JAMA Cardiology by Dr. David Prezant of Montefiore, Albert Einstein College of Medicine and FDNY.
Former professional cyclist, John Loehner, MD, an internal medicine physician and medical director at Montefiore Health System's Moses Campus, shares his experience on the frontline of the COVID-19 pandemic and how cycling has been key in helping him weather this storm.
In Dr. Ozuah’s NYT op-ed, he writes: “I see rare hope that these twin disasters disproportionately hurting minorities — one a brand-new virus and the other a virus as old as the country itself — could finally prove the true strength of our shared humanity.”
Montefiore-Einstein's research reveals nearly all newborns born to COVID-19-positive mothers tested negative for the disease immediately after birth, according to the largest body of data in the U.S. about pregnant women & COVID.
Dr. H. Michael Ushay of Children’s Hospital at Montefiore tells NY1 that Montefiore-Einstein has seen 37 Multisystem Inflammatory Syndrome in Children (MIS-C) patients, most of whom have been discharged, and the most reassuring aspect of the illness is how well children respond to treatment.
In the midst of a pandemic that has paralyzed the world, a CBS News team spent 7 days on the frontline at Montefiore-Einstein capturing the bravery and hope of our healthcare heroes who have been courageously fighting COVID-19.
Dr. Nadine Choueiter of Children’s Hospital at Montefiore speaks to NBC New York about rare cases of Pediatric Multisystem Inflammatory Syndrome (PMIS) related to COVID-19 and the importance of identifying symptoms so it can be treated.
Following promising results from NIH’s remdesivir trial, Montefiore-Einstein has begun testing a new drug combination as the next stage of the Adaptive COVID-19 Treatment Trial (ACTT2) — remdesivir and baricitinib. This may be the key to treating the most severe COVID-19 cases.
The Department of Pediatrics at Montefiore-Einstein conducted the largest single-center U.S. study researching how children are affected by COVID-19. While most children infected with COVID-19 have mild symptoms, a small number experience a severe response.
Dr. Philip O. Ozuah, CEO of Montefiore Medicine, spoke to MSNBC’s Morning Joe about testing, clinical trials, and the heroic fight, praising the courageous frontline workers at Montefiore.
New York Times' Nicholas Kristof tells the compelling story of Montefiore's ER Doctor Andres Maldonado who was diagnosed with COVID-19 and brought to the ICU after treating patients on the frontlines of the pandemic.
Researchers at Montefiore-Einstein conducted the largest study so far to assess outcomes for patients with cancer who have also been infected with #COVID19. The study, published in the online edition of Cancer Discovery, provides guidance on how to help protect this vulnerable patient population.
Montefiore-Einstein, one of the locations participating in the remdesivir clinical trial, has enrolled 91 patients in the study to test its effectiveness in treating #COVID19. Dr. Barry Zingman, Clinical Director, Infectious Diseases and Professor of Medicine, discusses promising early findings of remdesivir trial with NBC.
Doctors from Montefiore Health System applied for an emergency grant to purchase essential items such as diapers, wipes and formula for patient care packages. News 12 The Bronx highlights our #Monteheroes' efforts to get critical items directly to mothers and their babies in need amid the #COVID19 crisis.
Why do men infected by COVID-19 generally show more severe symptoms and why are they are more likely than women to die from the virus? Researchers at Montefiore-Einstein showed for the first time that men clear the virus from their bodies slower than women. The explanation: a potential male-only “reservoir” for coronavirus.
Dr. Liise-anne Pirofski, Chief of Infectious Disease, Department of Medicine at Montefiore Health System, speaks to CNN about a new clinical trial to treat individuals infected with COVID-19.